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Figure 1. Body size and lifespan in dogs.
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Explaining the staggering diversity in
organismal lifespan and ageing
patterns across species, populations
and individuals is a challenge of
ever-increasing importance in
modern biology and biomedicine. By
understanding the genetic, cellular and
environmental forces responsible for
this diversity, we may revolutionise our
ability to understand and control the
ageing process in our own species, as
well as in livestock and companion
animals. Evolutionary theory and
mounting empirical data suggest that
developmental trajectories and growth
rates can shape the onset and rate of
ageing in later life [1–3]. Large animal
species tend to live longer than small
species [3,4], although as with all
apparently general rules in biology,
there are important exceptions:
for instance, birds live exceptionally
long lives for their body size [2].
Paradoxically, within species the
relationship between body size and
lifespan shows the opposite trend to
cross-species comparisons: larger
individuals seem to live short lives.
Lower than average body mass and
relatively slow growth rate early in life
are positively correlated with longevity
within several vertebrate species ([5,6]
but see also [7]). So how canwe explain
these complex and at times conflicting
patterns?
The magnitude of the within-species
variation in size and lifespan seen
across dog breeds is particularly
striking. Consequently, man’s best
friend is rapidly emerging as an
important study species through
which to understand the causes ofvariation in the ageing process.
Through concentrated selection
pressure by humans for a range of
phenotypic traits over the last few
hundred years, over 400 breeds are
now described. Dogs show huge
variation in body size, with big breeds
such as St Bernard being over
two-orders of magnitude larger than
breeds such as Pekinese [8,9]. Canine
life expectancy is inversely correlated
with body mass (Figure 1), with
differences in lifespan across dog
breeds also being dramatic; small
breeds typically live much longer than
large breeds [8,9]. While it is well
established that big dogs die young,
the reasons for this are unclear. Are
big dogs simply more susceptible to
injury or infection, are they inherently
weaker in some way, do they start
growing old earlier or simply grow old
faster? There is evidence that smalland large dog breeds are differentially
susceptible to certain diseases [8],
with large dogs being more prone
to musculoskeletal, gastrointestinal
and neoplastic disorders, and small
dogs to endocrine-related disease.
Hormonal and genetic factors that
have been found to modulate lifespan
in model organisms [10] also vary
significantly across big and small
breeds [9,11].
A recent study by Kraus et al. [12]
aimed to find out whether the rate of
ageing is faster in larger dog breeds or
whether they have higher mortality
rates irrespective of age. This was done
using mortality information, body mass
and gender data from 74 dog breeds
collected between 1984 and 2004 from
North American veterinary teaching
hospitals. The explicit, non-mutually
exclusive hypotheses they tested were
that larger dog breeds die earlier
because a) there is an earlier onset of
senescence, b) there is a higher
minimum mortality hazard or c) there is
a greater rate of aging (Figure 2). Body
mass explained 44% of the variance in
mortality risk amongst breeds at the
onset of senescence, equating to a
reduction in lifespan of one month for
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Figure 2. Mortality and lifespan.
Illustration of the different aspects of the mortality curve that might vary to drive differences in
the longevity of different dog breeds. The heavy black curve represents the hazard trajectory
for comparison, with coloured dashed lines reflecting the four different ways in which
trajectories could vary.
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R452every 2 kg increase in mass. Perhaps
surprisingly, the age at which mortality
started increasing (i.e., senescence
mortality) did not differ significantly
across small and large breeds.
However, this onset in senescence did
occur somewhat earlier in giant breeds
(>50 kg), suggesting that these ‘giants’
might be physiologically frailer at an
earlier age. A clear positive relationship
between the absolute rate of aging and
body mass was detected, with the
mortality hazard increasing more
rapidly in larger breeds following the
onset of senescence. In a nutshell, the
data show that big dog breeds die
young because, once senescence
begins, they age more rapidly than
small breeds. It is important because it
tells us that the selection for increased
size has been accompanied by faster
aging.
As the authors acknowledge, the
data set they use is prone to a number
of unavoidable biases. For example,
information on age at death was
restricted to rather uneven categories,
resulting in the resolution of
information worsening with age:
the last two categories were simply
10–15 and greater than 15 years old.
Mortality following accidents is also
included, which may not be veryinformative for a study of senescence,
unless for some reason older dogs are
more prone to accidents. Bigger
breeds do show a slightly higher
baseline mortality, perhaps suggestive
of a greater risk of accidental death,
although previous research reports
that death from trauma does not
appear to differ between large and
small breeds [8]. The inherent nature
of such data sets also leads to
non-random selection of diseases,
ages, breeds and owner behaviour.
While the actual size of each breed
population was unknown, it was
assumed that both this and the age
distribution remained constant
throughout the 20 year study period.
Consequently, the number of healthy
dogs in each class was unknown, and
the popularity of different breeds is
known to wax and wane over time [13].
These assumptions do have the
potential to influence the study’s main
conclusions, but the association
between body size and the rate of
aging observed here does seem to be
strong. Replicate demographic studies
using data drawn from different kinds
of veterinary databases or other
countries could help establish the
generality and robustness of the
findings.Kraus et al. [12] fitted different
mortality hazard models to the dog
mortality data and consequently can
only provide insights into demographic
patterns in mortality across different
breeds. The challenge now is
to understand what biological
mechanisms underlie the apparent
differences among breeds in ageing
rate. This, of course, will not be a trivial
exercise but luckily potential clues may
help focus research efforts. Work
in model organisms has shown that
aging is plastic and that alterations in
components of various pathways,
particularly those related to
metabolism and growth, e.g. insulin/
IGF-1 signalling, can modulate both
lifespan and healthspan in a highly
conservative manner [10]. It is
interesting to note that small
dogs actually possess a distinct
polymorphism in the Igf1 gene
compared to large dogs [9], although
whether this is amodulator of ageing or
simply a by-product of selection for
body size has yet to be established.
Large dogs grow faster and for longer
than small dogs and also have higher
levels of IGF-1 [11], a powerful
stimulator of bone and muscle growth.
As with all things in life, too much of
anything can be bad and elevated
IGF-1 is associated with an increased
risk of certain diseases, including
cancer [14]. Interestingly, small dog
breeds have longer telomeres on
average, so this may also be part of the
jigsaw [15].
Life-history theory suggests
that resources are limited and
consequently animals can maximise
fitness only by trading metabolically
costly activities (growth, reproduction,
somatic maintenance) off against one
another. While in certain ecological
contexts a large body mass may be
advantageous (increased fecundity,
decreased predation risk), rapid
growth particularly early in life can
have negative fitness consequences
later in life [1,16]. As Kraus et al.
demonstrate in their analysis, being
large if you are a dog carries a lifespan
penalty. Consequently, it is worth
speculating on what the possible
mechanisms might be that mediate
the lifespan cost. It is well established
that rapid growth is correlated with
increased oxidative damage, greater
cellular senescence and telomere
shortening [17–19], and rapid
growth can also increase the risk
of disease, including certain cancers
Dispatch
R453[20], later in life. Interestingly, the
onset of senescence in giant dog
breeds appeared to occur at a time
at which these animals were still
growing.
The paper by Kraus et al. [12] tells
us why big dogs die young: a St
Bernard ages more rapidly following
the onset of senescence than a
Pekinese does. We now need to
focus in on potential mechanisms
driving these differences. On a more
cautionary note, dogs are rather
peculiar given that they have been
artificially selected for phenotypic
diversity, in stark contrast to more
routine model organisms primarily
selected for similarity. However,
there is no doubting that experimental
approaches leading on from the
work by Kraus et al. will complement
those studying ageing using
classical and non-classical model
organisms in the laboratory, and
under both semi-natural and
natural conditions. We suggest
that comparative approaches both
across and within species are likely to
give key insights into what
mechanisms underlie the ageing
process.
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Replacement of Disease VectorsTo fight human vector-borne diseases, first releases of sterile transgenic
mosquitoes have been performed. Someday, disease-refractory mosquitoes
will replace wild types to stop transmission. For such population replacements,
gene drive mechanisms must be established that allow local confinement and
reversibility.Ernst A. Wimmer
The fight against Malaria and
Dengue — the two major insect-borne
diseases in tropical and subtropical
areas — is threatened by the
increasingly fast evolution of
insecticide resistance in its insect
vectors. Therefore, alternative control
tools need to be included into pest
management strategies [1]. Insect
transgenesis promises to provide suchnovel tools through the establishment
of conditional reproductive sterility
or the refractoriness to disease
transmission [2,3]. In the transmission
of vector-borne diseases, the insect is
only a nuisance, but does not actually
cause the illness itself. This has led
to the long-standing hope that wild
mosquito populations could actually
be replaced by biotechnologically
engineered strains that would be
refractory to the disease causingpathogens, such as protists or
viruses [4,5], and therefore interrupt
disease transmission [3]. As the simple
replacement of a complete insect
population by a desired strain is
not feasible, strategies need to be
developed that cause population
replacement by changing the genetic
make-up of the population
through spreading the required
refractoriness-causing transgenes.
However, the transgenes providing
refractoriness to human disease
transmission are not likely to
spread through the population by
themselves. This requires effective
gene drive mechanisms that allow
for non-Mendelian inheritance and
‘selfish genes’ are thought to be some
of the best vehicles for such a gene
drive [6]. Conversely, there are
concerns on how to contain such
selfish genes and the accompanied
